Understand how QR Group’s regulatory affairs advice speeds up ANVISA approval for national and international manufacturers

With a focus on regulatory affairs, QR Group offers complete advice for product registration with ANVISA, aiming to ensure compliance and agility in accessing the Brazilian market. In this content, we explain how this personalized advice strengthens the entry of health products, national and foreign, into the country.

What are regulatory affairs?

Regulatory matters involve the entire process of legalization of health products with ANVISA. QR Group operates with more than 20 years of experience, helping companies to:

• Prepare required technical documentation

• Act as a legal representative for foreigners

• Advise from registration to go-to-market strategy

Business impacts

Regulating a product without guidance can lead to delays, fines, or rejection. With the advice of QR Group:

• Cause and effect: Compliance prevents disruptions to import and manufacturing

• Clarification: acting as a representative reduces costs and fiscal risks

• Emphasis: Faster market access and increased competitiveness

How QR Group helps

a) Proven experience

Team with more than two decades in regulatory quality and technical excellence

(b) Accountability and transparency

Act as third-party licensees, taking over registration on behalf of the company and reducing operating burdens

c) Complete strategy

From regulatory analysis to guidance to increase sales in national and foreign territory

Who can benefit

• Brazilian manufacturers looking for technical security

• International companies without headquarters in Brazil, which need a legal representative

• Businesses that want to reduce tax burdens and taxes

If you are looking for security, agility and expertise to register your products with ANVISA, QR Group’s regulatory affairs advice is the right choice. Contact us now and ensure full compliance with Brazilian standards!

Fonte: QR Group